Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol-Myers Squibb obtains rights to Kyorin antibiotic

Oct. 18, 1996

Proceedings report improved patient outcome with ADCON-L

Oct. 18, 1996

Pfizer discloses polycyclic ether antibiotics

Oct. 18, 1996

Patent coverage for Demeter BioTechnologies wound-healing proteins

Oct. 18, 1996

New antimigraine agents disclosed by Merck & Co.

Oct. 18, 1996

Faulding to distribute Carrington's hydrogel wound dressings

Oct. 18, 1996

Barr re-introduces generic drug for pain

Oct. 18, 1996

Tentative FDA approval for generic analgesic

Oct. 18, 1996

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

Atosiban efficacy in treating preterm labor

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026